EcoDrugPlus

Carbonic Anhydrase 12

Ensembl ID : ENSOMYG00000015551
Gene Symbol: CA12
1 Cross references
211 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSOMYG00000014583
Gene Symbol: CA4
2 Cross references
190 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSOMYG00000012310
Gene Symbol: CA4A
1 Cross references
207 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSOMYG00000009115
Gene Symbol: CA4A
2 Cross references
206 Possible Orthologues:

Carbonic Anhydrase Iv B

Ensembl ID : ENSOMYG00000039410
Gene Symbol: CA4B
1 Cross references
190 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSOMYG00000015221
Gene Symbol: CA7
1 Cross references
214 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSOMYG00000043557
Gene Symbol: CA7
1 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSOMYG00000006508
Gene Symbol: CA5A
1 Cross references
225 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSOMYG00000045866
Gene Symbol: CSNK1E
1 Cross references
190 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSOMYG00000013518
Gene Symbol: CSNK1E
1 Cross references
190 Possible Orthologues:

Caspase 9

Ensembl ID : ENSOMYG00000002381
Gene Symbol: CASP9
1 Cross references
196 Possible Orthologues:

Catechol-O-Methyltransferase A

Ensembl ID : ENSOMYG00000034879
Gene Symbol: COMTA
2 Cross references
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).